NorthAvenue LLC’s CME Group CME Stock Holding History

NorthAvenue LLC’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2	Closed	-$547	–	292
2025 Q4	$547	Buy	+2	New	+$543	﹤0.01%	259

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NorthAvenue LLC's CME Position: Q1 2026 in Review

NorthAvenue LLC sold out of CME Group (CME) in Q1 2026, closing a stake of 2 shares — an estimated $547 sold.

NorthAvenue LLC first reported a position in CME in Q4 2025 and held it in 1 quarter. The position peaked at $547 in Q4 2025. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

NorthAvenue LLC reported no remaining CME Group position as of Q1 2026 after selling out during the quarter.
NorthAvenue LLC sold 2 CME Group shares in Q1 2026, an estimated $547.
NorthAvenue LLC first reported a position in CME Group in Q4 2025 and held it in 1 quarter.
NorthAvenue LLC's CME Group position peaked at $547 in Q4 2025.
1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on NorthAvenue LLC's 13F filing for Q1 2026, filed 15 Apr 2026.